Abstract:An Ir/spiro[4,4]-1,6-nonadiene-based phosphine-oxazoline ligand (SpinPHOX) complex-catalyzed double asymmetric hydrogenation of 3,6-dialkylidene-1,4-dimethylpiperazine-2,5-diones has been developed, providing efficient and practical access to a wide variety of chiral 3,6-disubstituted-2,5-diketopiperazines in high yields with exclusive cis-diastereo- and excellent enantioselectivities (>99% de, up to 98% ee). The synthetic utilities of the protocol have been demonstrated in a gram scale synthesis of 6a and efficient construction of chiral products 8, 14, and 17 as well as a 2-butenyl-bridged bicyclic diketopiperazine 10 and hydroxydiketopiperazine 11. With an analogous achiral Ir catalyst, the hydrogenation of enantiopure monohydrogenated intermediate 7a gave cis-6a as the only product, indicating that the second-step hydrogenation of the titled transformation is a chiral substrate controlled process. The reaction profile study for asymmetric hydrogenation (AH) of 5a revealed that the concentration of the monohydrogenation intermediate 7a remained at a low level (<8%) during the course of hydrogenation. The hydrogenation of 5a to 6a proceeded significantly faster than that of its half-hydrogenated intermediate ( S)-7a, indicating that the titled reaction involves primarily a processive mechanism, in which a single catalyst molecule performs consecutive hydrogenation of the two C═C double bonds in substrate 5a without dissociation of the partially reduced 7a. The present protocol represents a rare example of asymmetric catalytic consecutive hydrogenation of heterocycles and provides an alternative way for efficient construction of cyclic dipeptides.

Large-Scale Enantioselective Reduction of 2,3-Disubstituted Indenopyridine Enables a Practical Manufacturing Process for an 11Β-Hsd-1 Inhibitor

Sequential C-H Arylation And Enantioselective Hydrogenation Enables Ideal Asymmetric Entry To The Indenopiperidine Core Of An 11 Beta-Hsd-1 Inhibitor

An Enantioselective Synthesis of an 11-Β-hsd-1 Inhibitor Via an Asymmetric Methallylation Catalyzed by (S)-3,3'-F2-BINOL.

Synthesis of Enantioenriched 2-Alkyl Piperidine Derivatives Through Asymmetric Reduction of Pyridinium Salts.

Development of a Practical Biocatalytic Process for ( S )- N -Boc-3-hydroxypiperidine Synthesis

Highly Enantioselective Synthesis Of 2,3-Dihydro-1h-Imidazo[2,1-A]Isoindol-5(9bh)-Ones Via Catalytic Asymmetric Intramolecular Cascade Imidization-Nucleophilic Addition-Lactamization

Enantioselective Construction of Cis-Hydroindole Scaffolds Via an Asymmetric Inverse-Electron-demand Diels–Alder Reaction: Application to the Formal Total Synthesis of (+)-Minovincine

Chiral Indolizidine Synthesis Through the Ir-Catalyzed Asymmetric Hydrogenation of Cyclic Pyridinium Salts.

Squaramide-catalysed Asymmetric Michael Addition/cyclization Cascade Reaction of 4-Arylmethylidene-2,3-dioxopyrrolidines with 2-Isothiocyanato-1-indanones.

Diastereoselective synthesis of chiral 3-substituted isoindolinones via rhodium(III)-catalyzed oxidative C-H olefination/annulation

Synthesis of Tetracyclic Indolines Through Palladium‐Catalyzed Asymmetric Dearomative Reaction of Aryl Iodides

Enantioselective Construction of 1 H -Isoindoles Containing Tri- and Difluoromethylated Quaternary Stereogenic Centers via Palladium-Catalyzed C–H Bond Imidoylation

Stereoselective Construction of 3-(Aminoalkylidene)oxindoles in One Pot: Development of a Novel, Robust, and Scalable Process for the Multigram-Scale Preparation of Nintedanib

Efficient Synthesis of Chiral Indolines Using an Imine Reductase from Paenibacillus Lactis

Ir-Catalyzed Double Asymmetric Hydrogenation of 3,6-Dialkylidene-2,5-diketopiperazines for Enantioselective Synthesis of Cyclic Dipeptides

Biocatalytic Synthesis of Ruxolitinib Intermediate via Engineered Imine Reductase

Iridium-Catalyzed Asymmetric Hydrogenation of 5-Hydroxypicolinate Pyridinium Salts under Batch and Flow: Stereodefined Access to Cis-Configurated Hydroxypiperidine Esters

Industrial Scale-Up of Enantioselective Hydrogenation for the Asymmetric Synthesis of Rivastigmine

Enantioselective 1,4-Reduction of Pyrimidin-2-ones to Synthesize Novel 3,4-Dihydropyrimidin-2(1H)-ones Containing an Alkyl-substituted Stereogenic Center

Asymmetric Intramolecular Amination Catalyzed with Cp*Ir-SPDO via Nitrene Transfer for Synthesis of Spiro-Quaternary Indolinone

Development of an Efficient and Scalable Biocatalytic Route to (1S,4r)-8-hydroxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl Propionate Via Enantioselective Enzymatic Desymmetrization of a Prochiral Diester